CLB stock news
This page provides real-time market news, earnings updates, and company announcements related to Core Laboratories Inc. (CLB).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-02 10:07 EST
DocGo's Q4 2025: What's Priced In After a Year of Misses?
101 finance2026-03-02 12:57:36
Tokyo Lifestyle's Hong Kong Subsidiary Enters into US$0.96 Million Loan Agreement with Principal Executive Officer
Finviz2026-03-02 13:03:56
VisionWave Holdings Closes and Funds $20 Million Senior Financing
Finviz2026-03-02 13:03:58
Claude Faces Major Service Outage as C3 AI Reports Sharp Revenue Drop and Restructuring Plan
101 finance2026-03-02 13:15:49
Will Mondelez Continue Its Strong Organic Sales Performance Into 2026?
101 finance2026-03-02 13:15:49
Telos Corporation to Announce Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026
Finviz2026-03-02 13:33:43
La Rosa Holdings CEO Provides Letter to Shareholders Outlining Operational Improvements, Reduced Cash Burn and Strategic Initiatives in 2026
Finviz2026-03-02 13:33:44
ROC Earns #1 Global Ranking in NIST ELFT Latent Fingerprint Benchmark, Strengthening Its Position in Mission-Critical Identity Security
Finviz2026-03-02 13:33:43
FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis
Finviz2026-03-02 13:33:44
FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis
Finviz2026-03-02 13:33:44
Sirius XM: Hidden Gem or Declining Investment?
101 finance2026-03-02 13:48:47
Lowe's Underperformance: A Sector Rotation or a Guidance Reset?
101 finance2026-03-02 13:21:55
In the latest earnings conference call, Paramount CEO Ellison praised HBO as the "crown jewel" of the group, emphasizing that this business segment will continue to receive ample resource support and maintain operational independence to sustain its core competitive advantage.
老虎证券2026-03-02 13:57:35
RadNet Makes $270 Million Bet On AI Future With Gleamer Buyout
Finviz2026-03-02 13:33:43
Optimist Fund's Views on Its Exited Position Fiverr International Ltd. (FVRR)
Finviz2026-03-02 14:00:50
3 Chemical Stocks with Diverse Portfolios to Monitor as Demand Challenges Persist
101 finance2026-03-02 14:03:48
L3Harris Technologies Inc (LHX) announces a major executive appointment
老虎证券2026-03-02 14:12:59
AIM ImmunoTech Inc. has signed an agreement to plan a proposed Phase III clinical trial of its core candidate drug Ampligen for the treatment of advanced pancreatic cancer.
老虎证券2026-03-02 14:13:58
FingerMotion Announces Results of Annual Meeting
Finviz2026-03-02 14:18:15
Should You Be Confident in FTAI Aviation (FTAI)?
Finviz2026-03-02 14:21:40
Berkshire Hathaway: Evaluating the Competitive Edge and Safety Margin After Buffett
101 finance2026-03-02 14:25:11
Optimist Fund's Reduction: Wise Move or Insider Scheme?
101 finance2026-03-02 14:25:00
Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Million Exclusive Agreement, Initiates Strategic Exit from Non-Core Businesses
Finviz2026-03-02 14:33:52
Beat the Market with Zacks: Spotlight on Contineum Therapeutics, Suzano, and PepsiCo
101 finance2026-03-02 14:36:43
Will Mondelez Continue Its Strong Organic Sales Performance Into 2026?
101 finance2026-03-02 13:15:49
Telos Corporation to Announce Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026
Finviz2026-03-02 13:33:43
La Rosa Holdings CEO Provides Letter to Shareholders Outlining Operational Improvements, Reduced Cash Burn and Strategic Initiatives in 2026
Finviz2026-03-02 13:33:44
ROC Earns #1 Global Ranking in NIST ELFT Latent Fingerprint Benchmark, Strengthening Its Position in Mission-Critical Identity Security
Finviz2026-03-02 13:33:43
FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis
Finviz2026-03-02 13:33:44
FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis
Finviz2026-03-02 13:33:44
Sirius XM: Hidden Gem or Declining Investment?
101 finance2026-03-02 13:48:47
Lowe's Underperformance: A Sector Rotation or a Guidance Reset?
101 finance2026-03-02 13:21:55
In the latest earnings conference call, Paramount CEO Ellison praised HBO as the "crown jewel" of the group, emphasizing that this business segment will continue to receive ample resource support and maintain operational independence to sustain its core competitive advantage.
老虎证券2026-03-02 13:57:35
RadNet Makes $270 Million Bet On AI Future With Gleamer Buyout
Finviz2026-03-02 13:33:43
Optimist Fund's Views on Its Exited Position Fiverr International Ltd. (FVRR)
Finviz2026-03-02 14:00:50
3 Chemical Stocks with Diverse Portfolios to Monitor as Demand Challenges Persist
101 finance2026-03-02 14:03:48
L3Harris Technologies Inc (LHX) announces a major executive appointment
老虎证券2026-03-02 14:12:59
AIM ImmunoTech Inc. has signed an agreement to plan a proposed Phase III clinical trial of its core candidate drug Ampligen for the treatment of advanced pancreatic cancer.
老虎证券2026-03-02 14:13:58
FingerMotion Announces Results of Annual Meeting
Finviz2026-03-02 14:18:15
Should You Be Confident in FTAI Aviation (FTAI)?
Finviz2026-03-02 14:21:40
Berkshire Hathaway: Evaluating the Competitive Edge and Safety Margin After Buffett
101 finance2026-03-02 14:25:11
Optimist Fund's Reduction: Wise Move or Insider Scheme?
101 finance2026-03-02 14:25:00
Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Million Exclusive Agreement, Initiates Strategic Exit from Non-Core Businesses
Finviz2026-03-02 14:33:52
Beat the Market with Zacks: Spotlight on Contineum Therapeutics, Suzano, and PepsiCo
101 finance2026-03-02 14:36:43
CLB stock chart
CLB stock detailsCLB stock price change
On the last trading day, CLB stock closed at 17.59 USD, with a price change of 1.09% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more